Our products

Developing innovative products and services in the clinical field and applying image analysis technologies that allow a personalized, economical, non-invasive and efficient medicine.

Non-invasive

To perform our diagnostic tests, it is only necessary for the doctor to perform an ultrasound image of the area, a technique that is totally harmless to patients.

Reliable

Our tests have the highest reliability in the market. Efficient and robust solutions, that reaches levels of precision, performance and reproducibility superior to conventional tests.

Fast

We have designed our tests as an easy-to-use web application: ultrasound images are uploaded, automatically analyzed and, in few minutes, the results are received. A simple and intuitive process.

Universal

They are recommended tests for the general population. quantusPREMATURITY is intended as a second trimester screening test for all pregnant women

“Personalized, predictive and non-invasive medicine is the future”

Dr. Eduard Gratacós

quantusFLM

Transmural Biotech has developed the first 100% non-invasive fetal lung maturity test, based on the analysis of an ultrasound image of the fetal lungs. It is an alternative to amniocentesis, easy to use and offers reliable results in a few minutes.

  • Non-Invasive

  • Pay per use 

  • Available 24×7

  • No installation requiered

MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusFLM

Transmural Biotech has developed the first 100% non-invasive fetal lung maturity test, based on the analysis of an ultrasound image of the fetal lungs. It is an alternative to amniocentesis, easy to use and offers reliable results in a few minutes.

  • Non-Invasive

  • Pay per use 

  • Available 24×7

  • No installation requiered

MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusPREMATURITY

Thanks to our work in R&D, we have developed the first robust test for an early detection of the spontaneous premature birth risk. By analyzing an ultrasound image of the cervix, we can detect cervical remodeling early. Thus, in a fast and reliable way, we provide the opportunity to obtain the risk of spontaneous premature birth.

  • General population oriented
  • Pay per use
  • Available 24×7
  • No installation required
MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusPREMATURITY

Thanks to our work in R&D, we have developed the first robust test for an early detection of the spontaneous premature birth risk. By analyzing an ultrasound image of the cervix, we can detect cervical remodeling early. Thus, in a fast and reliable way, we provide the opportunity to obtain the risk of spontaneous premature birth.

  • General population oriented
  • Pay per use
  • Available 24×7
  • No installation required
MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusSKIN

Our commitment to medicine and personalized diagnosis has led us to apply our technology to the evaluation of skin lesions.
Thus, at Transmural Biotech we have developed quantusSKIN, a robust, fast and easy-to-use test for the diagnosis and detection of malignant dermatological lesions from dermatoscopic images.

By simply analyzing and classifying the images, quantusSKIN determines the risk of malignancy (melanoma, basal cell carcinoma or squamous cell carcinoma), being of great help in screening patients with risk factors and prioritizing waiting lists.

  • General population oriented

  • Pay per use 

  • Available 24×7

  • No installation requiered

MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusSKIN

Our commitment to medicine and personalized diagnosis has led us to apply our technology to the evaluation of skin lesions.
Thus, at Transmural Biotech we have developed quantusSKIN, a robust, fast and easy-to-use test for the diagnosis and detection of malignant dermatological lesions from dermatoscopic images.

By simply analyzing and classifying the images, quantusSKIN determines the risk of malignancy (melanoma, basal cell carcinoma or squamous cell carcinoma), being of great help in screening patients with risk factors and prioritizing waiting lists.

  • General population oriented

  • Pay per use 

  • Available 24×7

  • No installation requiered

MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusGL

Glaucoma is one of the leading causes of blindness worldwide. Its early detection makes the difference. At Transmural Biotech we have developed quantusGL a non-invasive, fast and easy to use test for the diagnosis of glaucoma from fundus images of the retina.

Its technology is based on the quantitative analysis of the texture of the fundus image obtained by ocular retinography. By simply analyzing and classifying images, quantusGL determines the probability of presenting glaucoma in a few minutes, being of great help in screening patients with risk factors and prioritizing waiting lists.

  • General population oriented
  • Pay per use
  • Available 24×7
  • No installation required
MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusGL

Glaucoma is one of the leading causes of blindness worldwide. Its early detection makes the difference. At Transmural Biotech we have developed quantusGL a non-invasive, fast and easy to use test for the diagnosis of glaucoma from fundus images of the retina.

Its technology is based on the quantitative analysis of the texture of the fundus image obtained by ocular retinography. By simply analyzing and classifying images, quantusGL determines the probability of presenting glaucoma in a few minutes, being of great help in screening patients with risk factors and prioritizing waiting lists.

  • General population oriented
  • Pay per use
  • Available 24×7
  • No installation required
MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusMM

quantusMM is a non-invasive, quick, and easy-to-use test for the early detection of breast pathologies, developed in collaboration with the Basque Health Service Osakidetza and the Biodonostia Institute Association.
Its technology is based on the quantitative analysis of breast image texture. quantusMM classifies images and assigns them a category based on the BI-RADS (Breast Imaging-Reporting and Data System) system, which determines the probability of malignancy in the breast being analyzed, differing from the standard in that the categories are based on sensitivity values rather than positive predictive value.
quantusMM has been designed as a tool to assist clinicians, especially in mass screening processes for patients with risk factors, in the early detection of breast pathologies, and in prioritizing waiting lists.

  • General population oriented

  • Pay per use 

  • Available 24×7

  • No installation requiered

MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusMM

quantusMM is a non-invasive, quick, and easy-to-use test for the early detection of breast pathologies, developed in collaboration with the Basque Health Service Osakidetza and the Biodonostia Institute Association.
Its technology is based on the quantitative analysis of breast image texture. quantusMM classifies images and assigns them a category based on the BI-RADS (Breast Imaging-Reporting and Data System) system, which determines the probability of malignancy in the breast being analyzed, differing from the standard in that the categories are based on sensitivity values rather than positive predictive value.
quantusMM has been designed as a tool to assist clinicians, especially in mass screening processes for patients with risk factors, in the early detection of breast pathologies, and in prioritizing waiting lists.

  • General population oriented

  • Pay per use 

  • Available 24×7

  • No installation requiered

MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusRT

quantusRT is a non-invasive, fast, and easy-to-use test for detecting diabetic retinopathy from retinographic images. Its technology is based on quantitative analysis of the texture of the retinographic image. By simply analyzing and classifying images, quantusRT determines the risk of diabetic retinopathy in a matter of minutes.
The images are classified as benign or malignant, without the need (or as a complement) for a specialist to perform a visual inspection of the retinographic image. The specialist, who is always trained, classifies the images using visual patterns, and quantusRT gives a percentage risk of malignancy.
Mass screening of patients with risk factors, early detection of breast pathologies, and prioritization of waiting lists.

  • Aimed at the diabetic population

  • Pay per use
  • Available 24×7
  • No installation requiered

MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusRT

quantusRT is a non-invasive, fast, and easy-to-use test for detecting diabetic retinopathy from retinographic images. Its technology is based on quantitative analysis of the texture of the retinographic image. By simply analyzing and classifying images, quantusRT determines the risk of diabetic retinopathy in a matter of minutes.
The images are classified as benign or malignant, without the need (or as a complement) for a specialist to perform a visual inspection of the retinographic image. The specialist, who is always trained, classifies the images using visual patterns, and quantusRT gives a percentage risk of malignancy.
Mass screening of patients with risk factors, early detection of breast pathologies, and prioritization of waiting lists.

  • Aimed at the diabetic population

  • Pay per use
  • Available 24×7
  • No installation requiered

MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusOS

At Transmural Biotech, we have developed quantusOS, a non-invasive, fast, and easy-to-use test for the automatic detection of osteoporosis. Developed in collaboration with the Ramón y Cajal University Hospital in Madrid, Spain.

Images are classified into different categories according to the risk of osteoporosis. Based on a hip X-ray, it is able to detect the risk of osteoporosis. Its technology is based on the quantitative analysis of the texture of the femurs.

  • General population oriented

  • Pay per use 

  • Available 24×7

  • No installation requiered

MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusOS

At Transmural Biotech, we have developed quantusOS, a non-invasive, fast, and easy-to-use test for the automatic detection of osteoporosis. Developed in collaboration with the Ramón y Cajal University Hospital in Madrid, Spain.

Images are classified into different categories according to the risk of osteoporosis. Based on a hip X-ray, it is able to detect the risk of osteoporosis. Its technology is based on the quantitative analysis of the texture of the femurs.

  • General population oriented

  • Pay per use 

  • Available 24×7

  • No installation requiered

MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusTX

Our commitment to medicine has led us to apply our technology to develop quantusTX, a non-invasive, fast, reliable, and easy-to-use test for the automatic detection of pathologies detected in chest X-rays, such as atelectasis, consolidation, and pneumothorax.

It has been designed as a tool to assist clinicians, providing an automatic assessment of lung X-rays.

Simply analyzing the X-ray will provide results for the three pathologies.

  • General population oriented

  • Pay per use 

  • Available 24×7

  • No installation requiered

MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusTX

Our commitment to medicine has led us to apply our technology to develop quantusTX, a non-invasive, fast, reliable, and easy-to-use test for the automatic detection of pathologies detected in chest X-rays, such as atelectasis, consolidation, and pneumothorax.

It has been designed as a tool to assist clinicians, providing an automatic assessment of lung X-rays.

Simply analyzing the X-ray will provide results for the three pathologies.

  • General population oriented

  • Pay per use 

  • Available 24×7

  • No installation requiered

MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusRT-OCT

quantusRT-OCT® is a non-invasive, fast, reliable, and easy-to-use test for the automatic detection of pathological markers corresponding to microcysts and hyperreflective spots in diabetic retinopathy. The images used will be optical coherence tomography (OCT) scans.

It has been designed as a tool to assist clinicians, in particular by providing an automatic assessment of the quantitative analysis of different sections of the retina obtained by means of an ocular tomography.

  • Aimed at the diabetic population

  • Pay per use
  • Available 24×7
  • No installation requiered

MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

quantusRT-OCT

quantusRT-OCT® is a non-invasive, fast, reliable, and easy-to-use test for the automatic detection of pathological markers corresponding to microcysts and hyperreflective spots in diabetic retinopathy. The images used will be optical coherence tomography (OCT) scans.

It has been designed as a tool to assist clinicians, in particular by providing an automatic assessment of the quantitative analysis of different sections of the retina obtained by means of an ocular tomography.

  • Aimed at the diabetic population

  • Pay per use
  • Available 24×7
  • No installation requiered

MORE INFORMATION
for professionals
MORE INFORMATION
for patients
LOG IN
on application

Videos

Our products, especially quantusFLM, have presence in some videos: demonstrations of use, application in clinical cases, presentations at conferences…

Canal de Youtube de Colaboraciones

Collaborations

Canal Entrevistas Youtube

Interviews

Canal quantusFLM de YouTube

quantusFLM

Canal quantusPREMATURITY de Youtube

quantusPREMATURITY

Canal quantusSKIN de Youtube

quantusSKIN

Scientific references

quantusFLM

  • Evaluation of an improvement tool for non-invasive prediction of neonatal respiratory morbidity based on fully automated fetal lung ultrasound analysis
    Burgos-Artizzu XP, et al. Scientific Reports 
  • Prediction of neonatal respiratory morbidity by quantitative Ultrasound Lung Texture Analysis: a multicenter study
    Montse Palacio MD, PhD, Elisenda Bonet-carne MSc, PhD et als. American Journal of Obstetrics and Gynecology.
  • Quantitative Ultrasound Texture Analysis of Fetal Lungs to Predict Neonatal Respiratory Morbidity
    Bonet-Carne E, Palacio M, Cobo T, Perez-Moreno A, Lopez M, Piraquive JP, Ramirez JC, Marques F, Gratacos E. Ultrasound in bbstetrics & gynecolgy
  • Validation of a Quantitative Ultrasound Texture Analysis of Fetal Lungs to Predict Neonatal Respiratory Morbidity
    E. Bonet-Carne; M. Palacio; T. Cobo; A. Perez-Moreno; M. Lopez; J. Piraquive; J. Ramirez; F. Marques; E. Gratacos. Presented at XXIV European Congress of Perinatal Medicine of 2014.
  • Performance of an Automatic Quantitative Ultrasound Analysis of the Fetal Lung to Predict Fetal Lung Maturity
    M. Palacio; T. Cobo, M. Martínez-Terrón, G. Rattá, E. Bonet-Carne, I. Amat-Roldan and E. Gratacos. American journal of obstetrics & gynecology
  • BCNatal medical protocol for the use of corticosteroids
    Hospital Clinic – Hospital Sant Joan de Déu – Universidad de Barcelona
  • Antenatal corticosteroids: an assessment of anticipated benefits and potential risks
    Alan H. Jobe, MD, PhD; Robert L. Goldenberg, MD. American journal of obstetrics & gynecology

quantusPREMATURITY

  • Intra- and interobserver reproducibility of second trimester ultrasound cervical length measurement in a general population
    Núria Baños, Xavier P. Burgos-Artizzu, Brenda Valenzuela-Alcaraz, David Coronado-Gutiérrez, Álvaro Perez-Moreno, Júlia Ponce, Eduard Gratacós & Montse Palacio. The Journal of Maternal-Fetal & Neonatal Medicine (2020)
  • Mid‐trimester sonographic cervical consistency index to predict spontaneous preterm birth in a low‐risk population
    Baños N, Murillo‐Bravo C, Julià C, Migliorelli F, Perez‐Moreno A, Ríos J, Gratacos E, Valentin L, Palacio M.
    Ultrasound in obstretics & gynecology

  • Mid-Trimester Cervical Consistency Index and Cervical Length to Predict Spontaneous Preterm Birth in a High-Risk Population
    Baños N, Julià C, Lorente N, Ferrero S, Cobo T, Gratacos E, Palacio M.
    American Journal of Perinatology Reports

  • Quantitative analysis of cervical texture by ultrasound in mid‐pregnancy and association with spontaneous preterm birth
    Baños N, Perez‐Moreno A, Julià C, Murillo‐Bravo C, Coronado D, Gratacos E, Deprest J, Palacio M
    Ultrasound in obstetrics & gynecology

quantusSKIN

  • Skin cancer high-risk patient screening from dermoscopic images via Artificial Intelligence: an online study.
    David Coronado-Gutiérrez, Carlos López, Xavier P. Burgos-Artizzu 

quantusGL

  • Glaucoma patient screening from online retinal fundus images via Artificial Intelligence.
    Pablo Franco, David Coronado-Gutierrez, Carlos Lopez, Xavier P. Burgos-Artizzu 

Resources

If you want to read our corporate brochures on the use and advantages of our products, access our ‘Download Area’

Downloads